
Superparamagnetic Particles Market Report 2026
Global Outlook – By Types (Iron Oxide Particles, Cobalt Ferrite Particles, Nickel Ferrite Particles, Magnetite Particles), By Distribution Channel (Direct Sales, Distributors And Resellers, Online Retailers, Third-Party Platforms), By Application (Biomedical Applications, Magnetic Resonance Imaging (MRI), Drug Delivery Systems, Biosensors, Magnetic Separation), By End-User Industry (Healthcare And Life Sciences, Environmental Applications, Chemicals And Pharmaceuticals) – Market Size, Trends, Strategies, and Forecast to 2035
Superparamagnetic Particles Market Overview
• Superparamagnetic Particles market size has reached to $1.38 billion in 2025 • Expected to grow to $2.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.9% • Growth Driver: Surge In Personalized Medicine Driving Growth Of The Market Due To Advances In Genetic Testing • Market Trend: Advancements In Superparamagnetic Particle-Based Imaging Agents For Non-Invasive Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Superparamagnetic Particles Market?
Superparamagnetic particles are nanosized magnetic materials, usually made of iron oxides, that exhibit magnetism only when an external magnetic field is applied. They become magnetized in the presence of a field but lose this magnetization once the field is removed. Due to their small size and high magnetic sensitivity, they are widely used in biomedical applications such as MRI contrast agents, drug delivery, and magnetic separation. The main types of superparamagnetic particles are iron oxide particles, cobalt ferrite particles, nickel ferrite particles, magnetite particles, and others. Iron oxide particles refer to tiny particles made of iron and oxygen that exhibit magnetic properties and are widely used in biomedical, industrial, and environmental applications. It consists of different sizes, such as nanoscale (<100 nm), microscale (100 nm, 1 μm), and sub-microscale (1 μm, 10 μm), and is distributed through direct sales, distributors and resellers, online retailers, and third-party platforms. It finds applications in biomedical applications, magnetic resonance imaging (MRI), drug delivery systems, biosensors, and magnetic separation, serving end-user industries, including healthcare and life sciences, environmental applications, the food and beverage industry, electronics and consumer goods, and chemicals and pharmaceuticals.
What Is The Superparamagnetic Particles Market Size and Share 2026?
The superparamagnetic particles market size has grown rapidly in recent years. It will grow from $1.38 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to medical imaging advancements, nanotechnology research growth, biomedical diagnostics demand, laboratory separation techniques, material science innovation.What Is The Superparamagnetic Particles Market Growth Forecast?
The superparamagnetic particles market size is expected to see rapid growth in the next few years. It will grow to $2.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to precision medicine adoption, advanced drug delivery systems, biosensor development, healthcare diagnostics expansion, nano medicine research funding. Major trends in the forecast period include rising use in mri contrast imaging, growing adoption in targeted drug delivery, expansion in magnetic separation techniques, increased focus on nano scale particle design, advancements in surface functionalization.Global Superparamagnetic Particles Market Segmentation
1) By Types: Iron Oxide Particles, Cobalt Ferrite Particles, Nickel Ferrite Particles, Magnetite Particles 2) By Distribution Channel: Direct Sales, Distributors And Resellers, Online Retailers, Third-Party Platforms 3) By Application: Biomedical Applications, Magnetic Resonance Imaging (MRI), Drug Delivery Systems, Biosensors, Magnetic Separation 4) By End-User Industry: Healthcare And Life Sciences, Environmental Applications, Chemicals And Pharmaceuticals Subsegments: 1) By Iron Oxide Particles: Hematite Particles, Magnetite Particles, Maghemite Particles, Nanoparticles, Core Shell Particles 2) By Cobalt Ferrite Particles: Nanoparticles, Microspheres, Coated Particles, Doped Particles, Core Shell Particles 3) By Nickel Ferrite Particles: Nanoparticles, Hollow Particles, Porous Particles, Core Shell Particles, Surface Functionalized Particles 4) By Magnetite Particles: Nanocrystals, Microspheres, Superparamagnetic Particles, Coated Particles, Uncoated ParticlesWhat Is The Driver Of The Superparamagnetic Particles Market?
The increasing demand for personalized medicine is expected to drive the growth of the superparamagnetic particles market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to an individual’s genetic makeup, lifestyle, and environment to enhance treatment effectiveness and minimize side effects. The demand for personalized medicine is rising due to advances in genetic testing and precision diagnostics, which enable treatments to be customized for each patient. Superparamagnetic particles support personalized medicine by facilitating targeted drug delivery, molecular imaging, and diagnostic applications, contributing to improved therapeutic outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022, including seven cancer drugs and three for other diseases. Therefore, the increasing demand for personalized medicine is driving the growth of the superparamagnetic particles industry.What Is The Driver Of The Superparamagnetic Particles Market?
The increasing demand for personalized medicine is expected to drive the growth of the superparamagnetic particles market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to an individual’s genetic makeup, lifestyle, and environment to enhance treatment effectiveness and minimize side effects. The demand for personalized medicine is rising due to advances in genetic testing and precision diagnostics, which enable treatments to be customized for each patient. Superparamagnetic particles support personalized medicine by facilitating targeted drug delivery, molecular imaging, and diagnostic applications, contributing to improved therapeutic outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022, including seven cancer drugs and three for other diseases. Therefore, the increasing demand for personalized medicine is driving the growth of the superparamagnetic particles industry.Global Superparamagnetic Particles Market Trends and Insights
Major companies operating in the superparamagnetic particles market are focusing in developing advanced solutions, such as imaging agents, to allow for non-invasive visualization of internal structures. Imaging agents are compounds that improve the contrast of specific tissues or structures in the body to aid in medical imaging and diagnosis. For instance, in December 2023, Imagion Biosystems Limited, an Australia-based medical imaging company, announced positive findings after completing the IBI10103 phase I clinical trial, which evaluated the safety and clinical feasibility of MagSense HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for assessing axillary lymph node metastasis in patients with HER2+ primary breast cancer. It is built around a core of superparamagnetic iron oxide nanoparticles, manufactured at Imagion’s GMP-compliant facility in San Diego, CA. The nanoparticles are coated with biocompatible polymers and linked to the monoclonal antibody trastuzumab (Herceptin). MSH2IA is delivered as a single injection near the primary tumor site. It moves through the lymphatic system, selectively binding to HER2+ breast cancer cells to improve MRI visualization.What Are Latest Mergers And Acquisitions In The Superparamagnetic Particles Market?
In July 2024, Hologic Inc., a US-based medical technology company, acquired Endomagnetics Ltd. for $310 million. Through this acquisition, Hologic, Inc. aims to significantly strengthen and diversify its oncology portfolio by integrating Endomagnetics Ltd’s innovative magnetic surgical technologies, thereby enhancing its capabilities in advanced cancer diagnostics, minimally invasive treatment solutions, and overall patient care across various oncological applications. Endomagnetics Ltd. is a UK-based company that manufactures products that contain superparamagnetic particles.Regional Insights
North America was the largest region in the superparamagnetic particles market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Superparamagnetic Particles Market?
The superparamagnetic particles market consists of sales of dynabeads, magnetic separators and racks, dextran-coated magnetic beads, magnetic hyperthermia nanoparticles, and silica-coated magnetic nanoparticles. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Superparamagnetic Particles Market Report 2026?
The superparamagnetic particles market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the superparamagnetic particles industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Superparamagnetic Particles Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.55 billion |
| Revenue Forecast In 2035 | $2.43 billion |
| Growth Rate | CAGR of 12.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Types, Distribution Channel, Application, End-User Industry |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Miltenyi Biotec B.V. & Co. KG, Spherotech Inc., nanoComposix Inc., Nanoshel LLC, Cytodiagnostics Inc., Micromod Partikeltechnologie GmbH, Ocean NanoTech LLC, MagQu Co. Ltd., Bang Laboratories, JSR Life Sciences LLC, BioVision Inc., Creative Diagnostics, Ademtech SAS, Chemicell GmbH, Bangs Laboratories Inc., NanoMagnetics Ltd., Sphere Fluidics Ltd., Fluidic Analytics Ltd., Bio-Rad Laboratories Inc., Bio-Nano Consulting Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
